Citius Pharmaceuticals Inc (NASDAQ:CTXR) traded at $1.79 at last check on current trade day and made an upward move of 15.81% on its previous day’s price.
Looking at the stock we see that its previous close was $1.55 and the beta (5Y monthly) reads 1.179 with the day’s price range being $1.4 – $1.8. In terms of its 52-week price range, CTXR has a high of $26.75 and a low of $1.21. The company’s stock has gained about 8.79% over that past 30 days.
Citius Pharmaceuticals Inc has a market cap of $15.43 million and is expected to release its quarterly earnings report on 2025-Feb-13.
On the other hand, looking at the outlook for the CTXR stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Citius Pharmaceuticals Inc (CTXR) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 13.66% off its SMA20 and -15.91% from its 50-day simple moving average. The RSI (14) is pointing at 52.21 while the volatility over the past week is 16.06% and jumps to 10.86% over the past one month. The beta value is 1.17, while the average true range (ATR) is currently pointing at 0.21.
Coming back to Citius Pharmaceuticals Inc (NASDAQ:CTXR), we note that the average 3-month trading volume was 151.69K, while that of the preceding 10-day period stands at 0.13 million. Current shares outstanding are 8.59 million.
The insiders hold 5.74% of the company’s shares while institutions hold 8.33%. The data shows that short shares as of 2025-03-14, stood at 0.52 million at a short ratio of 2.93. This represents a 639.00 short interest in shares outstanding on 2025-03-14. Shares short fall in March from the previous month at 0.54 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -55.13% down in year-to-date price movement.
